$2.34Bn Growth for Mice Model Market Size to Hit 5.4% CAGR with CRISPR Segment Driving Growth During 2022-2028
July 25, 2023 09:19 ET
|
The Insight Partners
Pune, India, July 25, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Mice Model Market Size Report and Forecast to 2028 - COVID-19 Impact and Global...
United States Monkeypox Testing Market Outlook & Forecasts 2023-2025 Featuring Key Vendors - Abbott, F. Hoffmann-La Roche, Qiagen, and Thermo Fisher Scientific
April 12, 2023 10:28 ET
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "U.S. Monkeypox Testing Market - Industry Outlook & Forecast 2023-2025" report has been added to ResearchAndMarkets.com's offering.The U.S....
OTC/DTC Infectious Disease Diagnostics Global Market Report 2023: Benefits of Privacy and Anonymity Drive Growth
March 09, 2023 05:15 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by...
Insights on the Molecular Diagnostics for Infectious Disease Global Market to 2026 - Aging Population a Boon for All Diagnostics
January 16, 2023 07:38 ET
|
Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive...
Syndromic Multiplex Panels Global Market Report 2023: Lower Costs and Point of Care Advantage Drives Adoption
January 16, 2023 07:18 ET
|
Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country....
Veru Announces Appointment of Dr. David D. Ho as Chairman of its Infectious Disease Scientific Advisory Board
January 10, 2023 08:30 ET
|
Veru Inc.
MIAMI. FL, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
Syndromic Multiplex Diagnostic Global Market Report 2023: Speed of Diagnosis and Lower Costs Drive Adoption
January 05, 2023 08:48 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country,...
Two Female Scientists Win this year’s King Faisal Prize
January 04, 2023 13:57 ET
|
King Faisal Prize
Jeddah, Saudi Arabia, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Two women scientists were announced King Faisal Prize for Medicine and Science laureates for 2023: a Covid-19 vaccine developer and a...
OTC/DTC Infectious Disease Diagnostics Market Report 2023: New Sampling Technology and Rapid and Multiplex Tests Present Opportunities
January 04, 2023 07:03 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
December 19, 2022 08:00 ET
|
Assembly Biosciences, Inc.
In initial ABI-H3733 cohort of 50 mg in 28-day Phase 1b study, six of eight HBV patients on treatment reached lower limit of quantification for HBV DNA by day 21 and patients showed a mean reduction...